Pulmonary hypertension after bone marrow transplantation in children
Conclusion
Pulmonary hypertension is a severe complication of HSCT with an underestimated incidence and high mortality. Aggressive and timely up-front combination therapy allowed normalisation of pulmonary pressure and improved survival.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Levy, M., Moshous, D., Szezepanski, I., Galmiche, L., Castelle, M., Lesage, F., Dupic, L., Neven, B., Fischer, A., Blanche, S., Bonnet, D. Tags: Pulmonary vascular disease, Paediatric pulmonology Original Articles: Pulmonary hypertension and paediatrics Source Type: research
More News: Bone Marrow Transplant | Calcium | Cardiac Catheterization | Cardiology | Children | Heart | Heart Transplant | Hypertension | Pediatrics | PET Scan | Pulmonary Hypertension | Respiratory Medicine | Stem Cell Therapy | Stem Cells | Transplants